Found: 8
Select item for more details and to access through your institution.
Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail.
- Published in:
- Analytical & Bioanalytical Chemistry, 2014, v. 406, n. 18, p. 4453, doi. 10.1007/s00216-014-7849-x
- By:
- Publication type:
- Article
Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS).
- Published in:
- Analytical & Bioanalytical Chemistry, 2012, v. 402, n. 3, p. 1249, doi. 10.1007/s00216-011-5528-8
- By:
- Publication type:
- Article
Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model.
- Published in:
- Scientific Reports, 2016, p. 21868, doi. 10.1038/srep21868
- By:
- Publication type:
- Article
CAAP48, a New Sepsis Biomarker, Induces Hepatic Dysfunction in an in vitro Liver-on-Chip Model.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00273
- By:
- Publication type:
- Article
Preservation of Cell Structure, Metabolism, and Biotransformation Activity of Liver‐On‐Chip Organ Models by Hypothermic Storage.
- Published in:
- Advanced Healthcare Materials, 2018, v. 7, n. 2, p. 1, doi. 10.1002/adhm.201700616
- By:
- Publication type:
- Article
In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approach.
- Published in:
- Archives of Toxicology, 2016, v. 90, n. 2, p. 305, doi. 10.1007/s00204-014-1412-6
- By:
- Publication type:
- Article
Corrigendum: Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model.
- Published in:
- Scientific Reports, 2018, p. 46988, doi. 10.1038/srep46988
- By:
- Publication type:
- Article
The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS<sup>n</sup>.
- Published in:
- Drug Testing & Analysis, 2014, v. 6, n. 7/8, p. 746, doi. 10.1002/dta.1559
- By:
- Publication type:
- Article